Abstract
Cytokines are considered to be of major importance for the pathogenesis of several cutaneous disorders. Their considerable impact may result from autocrine, paracrine, or endocrine effects. Consequently, numerous investigations aim to measure cytokines, including interleukins. Since reliable determination of cutaneous interleukin expression at the protein level is problematic (see Notes 1–7), determination of mRNA expression came to the forefront of scientific interest. Such approaches, however, are associated with difficulties in the quantification of gene transcripts.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Christophers, E. and Sterry, W. (1993) Psoriasis, in Dermatology in General Medicine. (Fitzpatric, T. B., Eisen, A. Z., Wolff, K., Freedberg, I. M., and Austen, K. F., eds.), McGraw-Hill, New York, pp. 489–515.
Valdimarsson, H., Baker, B. S., Johnsdottir, I., and Fry, L. (1986) Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol. Today 7, 256–259.
Nickoloff, B. J. (1991) The cytokine network in psoriasis. Arch. Dermatol. 127, 871–884.
Uyemura, K., Yamamura, M., Fivenson, D. F., Modlin, R. L., and Nickoloff, B. J. (1993) The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J. Invest. Dermatol. 101, 701–705.
Schlaak, J. F., Buslau, M., Jochum, W., Hermann, E., Girndt, M. (1994) T cells involved in psoriasis vulgaris belong to the Th 1 subset. J. Invest. Dermatol. 102, 145–149.
Wrone-Smith, T. and Nickoloff, B. J. (1996) Dermal injection of immunocytes induces psoriasis. J. Clin. Invest. 98, 1878–1887.
Krueger, J. G., Krane, J. F., Carter, D. M., and Gottlieb, A. B. (1990) Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J. Invest. Dermatol. 94, 135S–140S.
Boehncke, W. H., Dressel, D., Manfras, B., Zollner, T. M., Wettstein, A., Böhm, B. O., et al. (1995) T-cell-receptor repertoire in chronic plaque-stage psoriasis is restricted and lacks enrichment of superantigen-associated Vβ regions. J. Invest. Dermatol. 104, 725–728.
Ohta, Y., Katayama, I., Funato, T., Yokozeki, H., Nishiyama, S., Hirano, T., et al. (1991) In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions. Arch. Derm. Res. 283, 351–356.
Lemster, B. H., Carroll, P. B., Rilo, H. R., Johnson, N., Nikaein, A., and Thomson, A. W. (1995) IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy. Clin. Exp. Immunol. 99, 148–154.
Ettehadi, P., Greaves, M. W., Wallach, D., Aderka, D., and Camp, R. D. (1994) Elevated tumor necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin. Exp. Immunol. 96, 146–151.
Asadullah, K., Prösch, S., Audring, H., Volk, H. D., Sterry, W., and Döcke, W. D. (1999) A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe psoriasis: an association with systemic TNF-overexpression. Br. J. Dermatol. 141, 94–102.
Olaniran, A. K., Baker, B. S., Paige, D. G., Garioch, J. J., Powles, A. V., and Fry, L. (1996) Cytokine expression in psoriatic skin lesions during PUVA therapy. Arch. Derm. Res. 288, 421–425.
D’Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., and Trinchieri, G. (1993) Interleukin 10 (IL10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178, 1041–1048.
De Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., and de Vries, J. E. (1991) Interleukin 10 (IL10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174,1209–1220.
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., and ÓGarra, A. (1991) IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815–3822.
Asadullah, K., Döcke, W. D., Haeußler, A., Sterry, W., and Volk, H. D. (1996) Progression of Mycosisfungoides is associated with increasing cutaneous expression of IL-10 mRNA.J. Invest. Dermatol. 107, 833–837.
Asadullah, K., Sterry, W., Stephanek, K., Leupold, M., Jasulaitis, D., Audring, H., et al. (1998) IL-10 is a key cytokine in psoriasis: proof of principle by IL-10 therapy—a new therapeutic approach. J. Clin. Invest. 101, 783–794.
Wang, A. M., Doyle, M. V., and Mark, D. F. (1989) Quantitation of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86, 9717–9721.
Platzer, C., Ode Hakim, S., Reinke, P., Döcke, W. D., Ewert, R., and Volk, H. D. (1994) Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation 58, 264–268.
Siegling, A., Lehmann, M., Platzer, C., Emmrich, F., and Volk, H. D. (1994) A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J. mmunol. Methods 177, 23–28.
Asadullah, K., Döcke, W. D., Ebeling, M., Friedrich, M., Belbe, G., Audring, H., et al. (1999) IL-10 treatment of psoriasis-clinical results of a Phase II trial, Arch. Dermatol. 135,187–192.
Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156–159.
Murphy, E., Hieny, S., Sher, A., and O’Garra, A.(1993) Detection of in vivo expression of interleukin-10 using a semi-quantitative polymerase chain reaction method in Schistosoma mansoni infected mice. J. Immunol. Methods 162,211–223.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Asadullah, K., Haeussler-Quade, A., Doecke, W.D., Sterry, W., Volk, HD. (2001). Measurement of Interleukins in Cutaneous Disorders. In: O’Neill, L.A.J., Bowie, A. (eds) Interleukin Protocols. Methods in Molecular Medicine™, vol 60. Springer, Totowa, NJ. https://doi.org/10.1385/1-59259-146-9:239
Download citation
DOI: https://doi.org/10.1385/1-59259-146-9:239
Publisher Name: Springer, Totowa, NJ
Print ISBN: 978-0-89603-738-0
Online ISBN: 978-1-59259-146-6
eBook Packages: Springer Protocols